TY  - RPRT
TI  - CIGB-300 synthetic peptide, an antagonist of CK2 kinase activity, as a treatment for Covid-19. A computational biology approach
AU  - Miranda, J.
AU  - Bringas, R.
AU  - de-Cossio, J. F.
AU  - Perera, Y.
PY  - 2021
DO  - 10.1101/2021.07.26.453805
UR  - https://www.biorxiv.org/content/10.1101/2021.07.26.453805v1
ID  - 10.1101/2021.07.26.453805
ER  -